news details |
|
|
| Rajnath Singh releases DRDO's anti-COVID drug, know about 2-deoxy-D-glucose | | | Agencies
New Delhi: Defence Minister Rajnath Singh on Monday (May 17, 2021) released the first batch of the anti-COVID-19 drug 2-deoxy-D-glucose (2-DG) to strengthen India's fight against the coronavirus. Union Health Minister Harsh Vardhan and AIIMS Delhi Director Dr Randeep Guleria were also present during the release.
Over 10,000 doses of the 2-DG drug, which comes in powder form and is taken orally by dissolving it in water, were launched.
The anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy's Laboratories (DRL), Hyderabad.
It was approved for emergency use as an adjunct therapy in moderate to severe COVID-19 patients by the Drugs Controller General of India (DCGI) on May 1.
Clinical trial results have shown that this molecule helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence. A higher proportion of patients treated with 2-DG showed RT-PCR negative conversion in COVID patients. The drug will be of immense benefit to the people suffering from COVID-19. |
|
|
|
|
|
|
|
|
|
|
|
|
| |
| |
|
|
|
|
 |
|
|
